These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33336224)

  • 41. Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
    Pentz R; Iulita MF; Ducatenzeiler A; Videla L; Benejam B; Carmona‐Iragui M; Blesa R; Lleó A; Fortea J; Cuello AC
    Alzheimers Dement; 2021 Apr; 17(4):605-617. PubMed ID: 33226181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical aging in Down syndrome.
    Zigman WB
    Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypersynchronized Magnetoencephalography Brain Networks in Patients with Mild Cognitive Impairment and Alzheimer's Disease in Down Syndrome.
    Ramírez-Toraño F; García-Alba J; Bruña R; Esteba-Castillo S; Vaquero L; Pereda E; Maestú F; Fernández A
    Brain Connect; 2021 Nov; 11(9):725-733. PubMed ID: 33858203
    [No Abstract]   [Full Text] [Related]  

  • 44. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.
    Walter S; Langford OG; Clanton TB; Jimenez-Maggiora GA; Raman R; Rafii MS; Shaffer EJ; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):234-241. PubMed ID: 32920625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.
    Wilcock DM; Schmitt FA; Head E
    Biochim Biophys Acta; 2016 May; 1862(5):909-14. PubMed ID: 26593849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome.
    Caraci F; Iulita MF; Pentz R; Flores Aguilar L; Orciani C; Barone C; Romano C; Drago F; Cuello AC
    Eur J Pharmacol; 2017 Dec; 817():7-19. PubMed ID: 28987272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down Syndrome Biobank Consortium: A perspective.
    Aldecoa I; Barroeta I; Carroll SL; Fortea J; Gilmore A; Ginsberg SD; Guzman SJ; Hamlett ED; Head E; Perez SE; Potter H; Molina-Porcel L; Raha-Chowdhury R; Wisniewski T; Yong WH; Zaman S; Ghosh S; Mufson EJ; Granholm AC
    Alzheimers Dement; 2024 Mar; 20(3):2262-2272. PubMed ID: 38270275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alzheimer's disease in Down syndrome: An overlooked population for prevention trials.
    Strydom A; Coppus A; Blesa R; Danek A; Fortea J; Hardy J; Levin J; Nuebling G; Rebillat AS; Ritchie C; van Duijn C; Zaman S; Zetterberg H
    Alzheimers Dement (N Y); 2018; 4():703-713. PubMed ID: 30581976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.
    Carmona-Iragui M; Santos T; Videla S; Fernández S; Benejam B; Videla L; Alcolea D; Blennow K; Blesa R; Lleó A; Fortea J
    J Alzheimers Dis; 2017; 55(4):1489-1496. PubMed ID: 27858714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer's disease and Down's syndrome: treating two paths to dementia.
    Weksler ME; Szabo P; Relkin NR; Reidenberg MM; Weksler BB; Coppus AM
    Autoimmun Rev; 2013 Apr; 12(6):670-3. PubMed ID: 23201920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer's disease development in adults with Down syndrome: Caregivers' perspectives.
    Ilacqua A; Benedict J; Shoben A; Skotko BG; Matthews T; Benson B; Allain DC
    Am J Med Genet A; 2020 Jan; 182(1):104-114. PubMed ID: 31639281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bidirectional Regulation of Amyloid Precursor Protein-Induced Memory Defects by Nebula/DSCR1: A Protein Upregulated in Alzheimer's Disease and Down Syndrome.
    Shaw JL; Zhang S; Chang KT
    J Neurosci; 2015 Aug; 35(32):11374-83. PubMed ID: 26269644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo quasi-elastic light scattering detects molecular changes in the lenses of adolescents with Down syndrome.
    Sarangi S; Minaeva O; Ledoux DM; Parsons DS; Moncaster JA; Black CA; Hollander J; Tripodis Y; Clark JI; Hunter DG; Goldstein LE
    Exp Eye Res; 2024 Apr; 241():109818. PubMed ID: 38422787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased plasma DYRK1A with aging may protect against neurodegenerative diseases.
    Delabar JM; Lagarde J; Fructuoso M; Mohammad A; Bottlaender M; Doran E; Lott I; Rivals I; Schmitt FA; Head E; Sarazin M; Potier MC
    Transl Psychiatry; 2023 Apr; 13(1):111. PubMed ID: 37015911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology.
    Handen BL; Lott IT; Christian BT; Schupf N; OBryant S; Mapstone M; Fagan AM; Lee JH; Tudorascu D; Wang MC; Head E; Klunk W; Ances B; Lai F; Zaman S; Krinsky-McHale S; Brickman AM; Rosas HD; Cohen A; Andrews H; Hartley S; Silverman W;
    Alzheimers Dement (Amst); 2020; 12(1):e12065. PubMed ID: 32775597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Alzheimer-type dementia and Down syndrome].
    Johannsen P; Mai J
    Ugeskr Laeger; 1995 Feb; 157(8):1021-4. PubMed ID: 7879299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alzheimer's disease associated with Down syndrome: a genetic form of dementia.
    Fortea J; Zaman SH; Hartley S; Rafii MS; Head E; Carmona-Iragui M
    Lancet Neurol; 2021 Nov; 20(11):930-942. PubMed ID: 34687637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Telomere longitudinal shortening as a biomarker for dementia status of adults with Down syndrome.
    Jenkins EC; Ye L; Krinsky-McHale SJ; Zigman WB; Schupf N; Silverman WP
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):169-74. PubMed ID: 26593971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down syndrome and beta-amyloid deposition.
    Head E; Lott IT
    Curr Opin Neurol; 2004 Apr; 17(2):95-100. PubMed ID: 15021233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer's disease and Down's syndrome: an in vivo MRI study.
    Beacher F; Daly E; Simmons A; Prasher V; Morris R; Robinson C; Lovestone S; Murphy K; Murphy DG
    Psychol Med; 2009 Apr; 39(4):675-84. PubMed ID: 18667098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.